awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q33370169-D05D2AA6-1BD6-4856-BA57-71DCB5C12D0F
Q33370169-D05D2AA6-1BD6-4856-BA57-71DCB5C12D0F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33370169-D05D2AA6-1BD6-4856-BA57-71DCB5C12D0F
Low molecular weight heparins: an emerging new class of glycosaminoglycan antithrombotics.
P2860
Q33370169-D05D2AA6-1BD6-4856-BA57-71DCB5C12D0F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33370169-D05D2AA6-1BD6-4856-BA57-71DCB5C12D0F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f59bb074a64f5fa3b3626dacf408d962fc8abe8c
P2860
A randomized controlled trial of a low-molecular-weight heparin (enoxaparin) to prevent deep-vein thrombosis in patients undergoing elective hip surgery.